BMS Appoints BD SVP

Frances Heller has been appointed senior vice president of business development, Bristol-Myers Squibb. Ms. Heller will report to Lamberto Andreotti, chief executive officer, and will be a member of the company’s senior management team.
 
Prior to joining the company, Ms. Heller was executive vice president of business development at Exelixis, where she accomplished several large, company-transforming transactions. Prior to that, Ms. Heller was head of Strategic Alliances at Novartis, where she was responsible for transactions with partners in the pharmaceutical and biotech industry as well as academic institutions worldwide.
 
“With broad experience across both the biotech and pharmaceutical industries, I believe Fran will be an important addition to my diverse management team and to the company,” said Mr. Andreotti, BMS. “In addition, her scientific, business and legal background, as well as her experience across therapeutic areas, will help BMS continue to execute its strategy of finding external innovation that complements our own internal R&D pipeline and helps us bring important new medicines to patients.”